Stenløse Kiropraktik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 4.6% 4.9% 5.1% 3.7%  
Credit score (0-100)  0 46 43 43 51  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 3,108 4,130 4,056 4,289  
EBITDA  0.0 42.9 121 -200 385  
EBIT  0.0 -245 -188 -531 53.4  
Pre-tax profit (PTP)  0.0 -265.7 -202.2 -568.0 29.2  
Net earnings  0.0 -213.8 -158.0 -444.0 22.5  
Pre-tax profit without non-rec. items  0.0 -266 -202 -568 29.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 475 683 559 436  
Shareholders equity total  0.0 1,034 876 432 454  
Interest-bearing liabilities  0.0 285 489 880 559  
Balance sheet total (assets)  0.0 2,198 2,074 1,785 1,498  

Net Debt  0.0 180 486 874 545  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 3,108 4,130 4,056 4,289  
Gross profit growth  0.0% 0.0% 32.9% -1.8% 5.8%  
Employees  0 6 8 8 6  
Employee growth %  0.0% 0.0% 33.3% 0.0% -25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 2,198 2,074 1,785 1,498  
Balance sheet change%  0.0% 0.0% -5.7% -13.9% -16.1%  
Added value  0.0 42.9 121.3 -221.6 385.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 1,439 -311 -664 -664  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 1.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% -7.9% -4.6% -13.1% 1.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -11.1% -8.8% -27.5% 3.3%  
ROI %  0.0% -14.3% -11.3% -34.0% 4.0%  
ROE %  0.0% -20.7% -16.5% -67.9% 5.1%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 47.0% 42.2% 24.2% 30.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 419.2% 400.9% -437.9% 141.5%  
Gearing %  0.0% 27.6% 55.8% 203.9% 123.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 14.7% 3.5% 5.3% 3.4%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.5 0.3 0.3 0.5  
Current Ratio  0.0 0.5 0.4 0.3 0.5  
Cash and cash equivalent  0.0 105.1 2.8 6.4 13.8  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -365.9 -488.7 -687.0 -414.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 7 15 -28 64  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 7 15 -25 64  
EBIT / employee  0 -41 -24 -66 9  
Net earnings / employee  0 -36 -20 -55 4